Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 36676 - 36700 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	CAPN9	10753	downregulated	entinostat results in decreased expression of CAPN9 mRNA	1q42.2	A21035
Entinostat	Investigational	CARD10	29775	upregulated	entinostat results in increased expression of CARD10 mRNA	22q13.1	A21035
Entinostat	Investigational	CARD19	84270	upregulated	entinostat results in increased expression of CARD19 mRNA	9q22.31	A21037
Entinostat	Investigational	CARD8-AS1	100505812	downregulated	entinostat results in decreased expression of CARD8-AS1 mRNA	19q13.33	A21035
Entinostat	Investigational	CARS	833	downregulated	entinostat results in decreased expression of CARS mRNA	11p15.4	A21035
Entinostat	Investigational	CARS	833	upregulated	entinostat results in increased expression of CARS mRNA	11p15.4	A21037
Entinostat	Investigational	CARTPT	9607	downregulated	entinostat results in decreased expression of CARTPT mRNA	5q13.2	A21035
Entinostat	Investigational	CASC10	399726	upregulated	entinostat results in increased expression of CASC10 mRNA	10p12.31	A21037
Entinostat	Investigational	CASP8	841	upregulated	entinostat results in increased expression of CASP8 mRNA	2q33.1	A21037
Entinostat	Investigational	CAST	831	downregulated	entinostat results in decreased expression of CAST mRNA	5q15	A21037
Entinostat	Investigational	CAST	831	upregulated	entinostat results in increased expression of CAST mRNA	5q15	A21035
Entinostat	Investigational	CAV2	858	upregulated	entinostat results in increased expression of CAV2 mRNA	7q31.2	A21035
Entinostat	Investigational	CBFB	865	downregulated	entinostat results in decreased expression of CBFB mRNA	16q22.1	A21037
Entinostat	Investigational	CBLC	23624	upregulated	entinostat results in increased expression of CBLC mRNA	19q13.32	A21037
Entinostat	Investigational	CBLN1	869	upregulated	entinostat results in increased expression of CBLN1 mRNA	16q12.1	A21037
Entinostat	Investigational	CBLN2	147381	downregulated	entinostat results in decreased expression of CBLN2 mRNA	18q22.3	A21035
Entinostat	Investigational	CBR3	874	upregulated	entinostat results in increased expression of CBR3 mRNA	21q22.12	A21037
Entinostat	Investigational	CBS	875	upregulated	entinostat results in increased expression of CBS mRNA	21q22.3	A21037
Entinostat	Investigational	CBX5	23468	downregulated	entinostat results in decreased expression of CBX5 mRNA	12q13.13	A21035
Entinostat	Investigational	CCDC114	93233	upregulated	entinostat results in increased expression of CCDC114 mRNA	19q13.33	A21035
Entinostat	Investigational	CCDC121	79635	downregulated	entinostat results in decreased expression of CCDC121 mRNA	2p23.3	A21037
Entinostat	Investigational	CCDC13	152206	upregulated	entinostat results in increased expression of CCDC13 mRNA	3p22.1	A21037
Entinostat	Investigational	CCDC136	64753	downregulated	entinostat results in decreased expression of CCDC136 mRNA	7q32.1	A21037
Entinostat	Investigational	CCDC140	151278	upregulated	entinostat results in increased expression of CCDC140 mRNA	2q36.1	A21037
Entinostat	Investigational	CCDC151	115948	upregulated	entinostat results in increased expression of CCDC151 mRNA	19p13.2	A21037 A21035

Displaying entries 36676 - 36700 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability